Taysha Gene Therapies Reports Quarter Ended June 30, 2026 Results

What Happened

• Taysha Gene Therapies, Inc. (TSHA) announced and furnished a press release on August 11, 2026 reporting its financial results and recent business highlights for the quarter ended June 30, 2026. The press release is attached to the Form 8-K as Exhibit 99.1 and is incorporated by reference.

Key Details

• Filing date: August 11, 2026 (Current Report on Form 8-K, Item 2.02).
• Reporting period: quarter ended June 30, 2026.
• Disclosure: financial results and recent business highlights presented in a press release (Exhibit 99.1).
• The Form 8-K also includes the interactive XBRL cover page (Item 9.01 exhibits).

Why It Matters

• This filing provides the company’s latest quarterly results and operating updates investors use to assess performance, cash position, and progress on clinical or business milestones. Retail investors should read the attached press release for the specific financial figures (revenue, net loss, cash runway) and any management commentary or updates on programs announced in the release.